Blockchain Registration Transaction Record

InMed Pharmaceuticals Announces Promising Results for Alzheimer's Drug Candidate

InMed Pharmaceuticals announces promising outcomes from a long-term preclinical study of its Alzheimer’s Disease drug candidate, INM-901, confirming and expanding upon previous results.

InMed Pharmaceuticals Announces Promising Results for Alzheimer's Drug Candidate

This news matters as it represents a significant step forward in the development of a potential treatment for Alzheimer’s Disease, a condition with high unmet medical needs.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x8199af929f85583033d1290ff39988ac68627071c0cc1bd91f3e340d3232f541
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintechocQN1-7d78cccfe98ef375f1d8d233fc22bd21